Non-small-cell lung cancer

Lung Cancer: Blocking GH Receptor Boosts Treatment

by

A decades-old drug, initially developed to treat a rare hormonal disorder, is showing remarkable promise as a potential weapon against the most deadly form of lung cancer. Researchers at Ohio University have discovered that blocking the growth hormone receptor (GHR) can significantly enhance the effectiveness of chemotherapy in Non-Small Cell Lung Cancer (NSCLC), a disease … Read more

Lung Cancer: Timing Immunotherapy for Better Results

by

Timing Matters: Chemotherapy Infusion Schedule Significantly Impacts Lung Cancer Progression New research reveals a critical factor in the fight against advanced non-small cell lung cancer: when patients receive their chemotherapy infusions. A groundbreaking phase 3 clinical trial demonstrates that administering chemotherapy, in combination with either sintilimab or pembrolizumab, earlier in the day—before 3:00 PM—leads to … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]